Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

Global Blockchain Colloquium 2021 organized by MIT Centre for Future Skills Excellence

Published

on

 

India is inching closer to regulating cryptocurrencies within its borders. And soon the phased implementation strategy for central bank digital currency (CBDC) will be rolled out. MIT Centre for Future Skills Excellence, a flagship initiative of MIT Art, Design and Technology University, Pune, concluded its 3-day Global Blockchain Colloquium on August 9, 2021. This is the largest blockchain colloquium ever held in an online mode addressed by 22+ international blockchain experts, and industry leaders to discuss the latest hot spots, use cases, tips, trends, insights and technological frontiers of blockchain technology.

The Valedictory keynote sessions were graced by Mr. Anthony Day – Blockchain Leader, Global Business Services, IBM Ireland, Mr. Andrea Frosinini- Senior Enterprise Analyst & Trade Finance Evangelist, Italy, Mr. Prasanna Lohar– Head Digital Innovation & Architecture, DCB Bank, Dr. Mohit Dubey -CEO, AIC-MITADT Incubator Forum, Prof. Dr. Atul Patil – Director, MIT School of Holistic Development and Prof. Suraj Bhoyar – Project Director, MIT Centre for Future Skills Excellence, MIT ADT University, Pune, India.

MIT Centre for Future Skills Excellence had organised the Global Blockchain Colloquium in association with India Blockchain Forum, Global Blockchain Business Council, & AIC-MITADT Incubator Forum from August 7 to 9, 2021. The Global Blockchain Colloquium was co-hosted by Blockchain ThinkLab of University at Buffalo, DCB Bank, Association for Emerging Technologies, IDEALABS Future Tech Ventures, EarthID, Stezy.io, SettleMint, Snapper FutureTech, Future Money WALLET and Aurigraph.io. The Global Blockchain Colloquium was an exemplary 3-day conclave on the most quintessential concepts related to Blockchain, Crypto, Tokens and Cybersecurity. Over a period of three days, the colloquium captivated the participants from over 21+ countries around the world. The colloquium is among the first of many efforts to transform India into a global blockchain powerhouse. The international event, one of its own kind, witnessed around 500+ blockchain enthusiasts including UG & PG Students, research scholars, faculty members, startup owners, and industry professionals.

The Global Blockchain Colloquium was aimed at bringing thought-provoking conversations on blockchain for enterprises, next generation financial services, developing blockchain applications, decentralized applications, and decentralized finance (DeFi), digital identity, sustainability & blockchain technologies for Central Bank Digital Currency, blockchain for trade finance, and blockchain platforms.

MIT Art, Design & Technology University, PuneIndia has always been a flag-bearer of engineering and technology in the country and has been at the forefront of offering innovative & industry relevant programmes including disruptive technologies,” said Prof. Dr. Mangesh Karad, Executive President & Vice Chancellor. “Continuing this tradition, we have also been deeply involved in blockchainAI & MLCloud ComputingCybersecurityRobotic Process Automation development & have been fostering a powerful support ecosystem across India, he said.

Global Blockchain Leader & Digital Strategist, Mr. Anthony Day congratulated & appreciated the endeavours by the MIT Centre for Future Skills Excellence for organising this one of its own kind Global Blockchain Colloquium during the valedictory address. He shared his insights on use cases for accelerating post-pandemic transformation in supply chain, identity & sustainability. He also expressed his best wishes to MIT-ADT University that had taken up the mammoth task of promoting future skills for today’s and future generation.

Mr. Andrea Frosinini from Hyperledger TF-SIG deliberately answered how blockchain can be applied in an effective and cost-efficient way within trade finance. He said, “Blockchain technology holds the potential to change business processes by redefining value chain interactions, reducing operational complexity, and reducing transaction costs.”

Mr. Prasanna Lohar, Head Digital Innovation &Architecture, DCB Bank pointed out that the journey of emerging technologies is going really at a very fast pace in India. He reiterated, “Along with educational giants like MIT-ADT University, we are looking forward to taking the first step, i.e. creating a superior curriculum for a better ecosystem for emerging technologies and specifically in blockchain technology. He complimented the team MIT Centre for Future Skills Excellence (MIT-FuSE) for bringing the Global Blockchain Colloquium 2021 with more synergy & relevant keynote sessions for the common benefit of global workplaces, as well as challenges in emerging technology for generation Z.

Dr. Mohit Dubey, CEO-AIC MITADT Incubator Forum stated, “Thanks to Fintech, technologies speak for finances, and innovations are only the beginning. Fintech is disrupting nearly every area of startups & businesses. A future where AI-boosted investment and advising platforms, blockchain-technology-enabled cryptocurrencies, are prevalent in every area of commerce and finance might be a way off.” He pointed out that the time was right for sessions like these to create awareness in these emerging technologies and congratulated MIT-FuSE on its 3-day exclusive deliberations. This would shape up the future generation and economy.

Blockchain is not new to India. It is being highlighted more with the introduction of e-RUPI & CBDC. India has a lot to gain from embracing blockchain technology and exploring it further. The first pre-requisite is creation of new career opportunities. Considerable job growth has been seen for positions like Blockchain Developers & Blockchain Architects in government agencies and other sectors such as retail, eCommerce, supply chain management, healthcare, education, agriculture, banking, etc. Blockchain developers can earn more than 50% than the other jobs in the IT market today. It means that there are innumerable high-paying jobs from all over the world now available to Indian developers in blockchain technology.

Prof. Suraj Bhoyar, Project Director summarised the gist of the sessions which were conducted over the period of three days. He specified that MIT Centre for Future Skills Excellence is connecting and aligning with leading industries with the sole purpose of providing students and working professionals from all walks of the life, access to quality education and industry-relevant curriculum to ensure that they succeed in their careers. As the first step towards this, MIT Centre for Future Skills Excellence will be commencing with its Post Graduate Programme in Blockchain Technology soon. He said, “We are so humbled and overwhelmed by the huge response to this GBC 2021. And we had a great time interacting with the participants from countries like USAEnglandSingaporeSwitzerlandNigeriaMoroccoCyprusBrazilItalyIrelandBelgiumNetherlandsNew ZealandSouth AfricaGermanyUnited Arab EmiratesVietnamSri LankaIsrael, etc.”

The colloquium highlighted the latest& upcoming trends in the blockchain industry, provided an opportunity to meet industry leaders, helped to network with like-minded people & observed collaboration opportunities. The participants had a great fortune to listen to the distinguished keynote speakers across the globe on topics like viz. Blockchain Technology -Implementation & Governance, Blockchain Platforms, Digital Identity with KYC-Use Cases, Sustainability with Blockchain, Blockchain & Decentralized Applications, Crypto Metrics, Indexes & Stacks, Central Bank Digital Currency (CBDC), Blockchain Platforms as a Service, Global View of blockchain use-cases, Blockchain Reality vs Hype, Blockchain and Security, Decentralized Finance (DeFi),How Blockchain and Trade Finance delivering Global Solutions, Enterprise Blockchain for use cases in Supply Chain, Identity and Sustainability.

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Continue Reading

Trending